Long-term effects of laparoscopic lateral pelvic lymph node dissection on urinary retention in rectal cancer
- 22 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Surgical Endoscopy
- Vol. 36 (2), 999-1007
- https://doi.org/10.1007/s00464-021-08364-7
Abstract
Background The addition of lateral pelvic lymph node dissection (LPLND) in rectal cancer surgery has been reported to increase the incidence of post-operative urinary retention. Here, we assessed the predictive factors and long-term outcomes of urinary retention following laparoscopic LPLND (L-LPLND) with total mesorectal excision (TME) for advanced lower rectal cancer. Methods This retrospective single-institutional study reviewed post-operative urinary retention in 71 patients with lower rectal cancer who underwent L-LPLND with TME. Patients with preoperative urinary dysfunction or who underwent unilateral LPLND were excluded. Detailed information regarding patient clinicopathologic characteristics, post-void residual urine volume, and the presence or absence of urinary retention over time was collected from clinical and histopathologic reports and telephone surveys. Urinary retention was defined as residual urine > 100 mL and the need for further treatment. Results Post-operative urinary retention was observed in 25/71 patients (35.2%). Multivariate analysis revealed that blood loss ≥ 400 mL [odds ratio (OR) 4.52; 95% confidence interval (CI) 1.24–16.43; p = 0.018] and inferior vesical artery (IVA) resection (OR 8.28; 95% CI 2.46–27.81; p < 0.001) were independently correlated with the incidence of urinary retention. Furthermore, bilateral IVA resection caused urinary retention in more patients than unilateral IVA resection (88.9% vs 47.1%, respectively; p = 0.049). Although urinary retention associated with unilateral IVA resection improved relatively quickly, urinary retention associated with bilateral IVA resection tended to persist over 1 year. Conclusion We identified the predictive factors of urinary retention following L-LPLND with TME, including increased blood loss (≥ 400 mL) and IVA resection. Urinary retention associated with unilateral IVA resection improved relatively quickly. L-LPLND with unilateral IVA resection is a feasible and safe procedure to improve oncological curability. However, if oncological curability is guaranteed, bilateral IVA resection should be avoided to prevent irreversible urinary retention.Keywords
Funding Information
- Japan Society for the Promotion of Science (20K17621)
This publication has 40 references indexed in Scilit:
- The risk factors for urinary dysfunction after autonomic nerve-preserving rectal cancer surgery: a multicenter retrospective study at Yokohama Clinical Oncology Group (YCOG1307)International Journal of Colorectal Disease, 2019
- Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212)European Journal of Surgical Oncology, 2018
- Predictors of Postoperative Urinary Retention After Colorectal SurgeryDiseases of the Colon & Rectum, 2013
- Impact of Autonomic Nerve Preservation and Lateral Node Dissection on Male Urogenital Function after Total Mesorectal Excision for Lower Rectal CancerWorld Journal of Surgery, 2006
- A prospective study of sexual and urinary function before and after total mesorectal excision with autonomic nerve preservation for rectal cancerSurgery, 2002
- Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgeryBritish Journal of Surgery, 2001
- Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapyDiseases of the Colon & Rectum, 2001
- Rectal CancerArchives of Surgery, 1998
- Improved survival in patients with rectal cancer: a population-based register studyBritish Journal of Surgery, 1998
- Mesorectal excision for rectal cancerThe Lancet, 1993